Securin predicts aneuploidy and survival in breast cancer

: Karra H, Pitkanen R, Nykanen M, Talvinen K, Kuopio T, Soderstrom M, Kronqvist P

Publisher: WILEY-BLACKWELL

: 2012

Histopathology

: HISTOPATHOLOGY

: 4

: 60

: 4

: 586

: 596

: 11

: 0309-0167

DOI: https://doi.org/10.1111/j.1365-2559.2011.04107.x

Conclusions: The main result of the present study is the association of aneuploidy and securin expression. According to our results, securin immunohistochemistry is also a potential new prognosticator for treatment decisions concerning breast cancer patients.